Raymond James Trust N.A. bought a new stake in shares of Veeva Systems Inc. (NYSE:VEEV – Free Report) in the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm bought 1,099 shares of the technology company’s stock, valued at approximately $231,000.
A number of other hedge funds have also recently bought and sold shares of the company. Mowery & Schoenfeld Wealth Management LLC bought a new position in shares of Veeva Systems in the third quarter valued at $26,000. Advisors Asset Management Inc. acquired a new position in shares of Veeva Systems in the 1st quarter worth $28,000. Blue Trust Inc. raised its position in shares of Veeva Systems by 3,460.0% during the second quarter. Blue Trust Inc. now owns 178 shares of the technology company’s stock worth $33,000 after purchasing an additional 173 shares during the period. DT Investment Partners LLC purchased a new stake in shares of Veeva Systems during the second quarter valued at $35,000. Finally, Mather Group LLC. boosted its position in shares of Veeva Systems by 166.3% in the 2nd quarter. Mather Group LLC. now owns 253 shares of the technology company’s stock valued at $46,000 after purchasing an additional 158 shares during the period. 88.20% of the stock is owned by institutional investors and hedge funds.
Veeva Systems Stock Down 0.1 %
Shares of VEEV stock opened at $226.76 on Friday. Veeva Systems Inc. has a 12 month low of $165.12 and a 12 month high of $240.68. The company has a market cap of $36.72 billion, a PE ratio of 60.47, a price-to-earnings-growth ratio of 2.19 and a beta of 0.81. The business’s 50 day moving average is $215.45 and its two-hundred day moving average is $201.83.
Insider Activity
In other news, insider Thomas D. Schwenger sold 1,126 shares of the stock in a transaction that occurred on Friday, November 8th. The stock was sold at an average price of $240.01, for a total value of $270,251.26. Following the completion of the sale, the insider now directly owns 27,013 shares of the company’s stock, valued at approximately $6,483,390.13. This represents a 4.00 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. 10.50% of the stock is currently owned by company insiders.
Wall Street Analyst Weigh In
VEEV has been the subject of a number of analyst reports. Truist Financial upped their price objective on shares of Veeva Systems from $197.00 to $207.00 and gave the company a “hold” rating in a research note on Tuesday, September 3rd. Piper Sandler raised their price objective on shares of Veeva Systems from $230.00 to $280.00 and gave the stock an “overweight” rating in a research note on Friday, November 8th. StockNews.com raised shares of Veeva Systems from a “hold” rating to a “buy” rating in a research note on Saturday, November 9th. UBS Group raised their target price on Veeva Systems from $185.00 to $215.00 and gave the stock a “neutral” rating in a research report on Monday, August 26th. Finally, BNP Paribas assumed coverage on Veeva Systems in a research report on Tuesday, October 8th. They set an “outperform” rating and a $286.00 price target on the stock. One analyst has rated the stock with a sell rating, eight have issued a hold rating and sixteen have given a buy rating to the company’s stock. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average target price of $236.92.
Check Out Our Latest Research Report on Veeva Systems
Veeva Systems Company Profile
Veeva Systems Inc provides cloud-based software for the life sciences industry. It offers Veeva Commercial Cloud, a suite of software and analytics solutions, such as Veeva customer relationship management (CRM) that enable customer-facing employees at pharmaceutical and biotechnology companies; Veeva Vault PromoMats, an end-to-end content and digital asset management solution; Veeva Vault Medical that provides source of medical content across multiple channels and geographies; Veeva Crossix, an analytics platform for pharmaceutical brands; Veeva OpenData, a customer reference data solution; Veeva Link, a data application that allows link to generate real-time intelligence; and Veeva Compass includes de-identified and longitudinal patient data for the United States.
Further Reading
- Five stocks we like better than Veeva Systems
- How Investors Can Identify and Successfully Trade Gap-Down Stocks
- Eli Lilly, Pfizer, and AstraZeneca: 2025 Vaccine Makers to Watch
- Are These Liquid Natural Gas Stocks Ready For An Upside Bounce?
- DICK’S Sporting Goods: The Under-the-Radar Buy-and-Hold Winner
- Stock Ratings and Recommendations: Understanding Analyst Ratings
- 2 Cheap Quantum Computing Stocks to Buy Instead of Chasing IonQ
Receive News & Ratings for Veeva Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Veeva Systems and related companies with MarketBeat.com's FREE daily email newsletter.